Skip to main content
PMC home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 2007 Sep;79(1):9–17.

Effect of Dietary Substitution of Groundnut Oil on Blood Glucose, Lipid Profile, and Redox Status in Streptozotocin-diabetic Rats

B Ramesh 1, R Saravanan 1, KV Pugalendi 1,*
PMCID: PMC1942175  PMID: 17876371

Abstract

The effect of groundnut oil on blood glucose, lipid profile, lipid peroxidation, and antioxidant status in streptozotocin-diabetic rats was investigated and compared with diabetic and drug-treated rats. Diabetes was induced in adult female Wistar rats by intraperitoneal administration of streptozotocin (40 mg/kg b-wt). Normal and diabetic rats were fed an oil-free diet containing 2 percent oil supplemented with groundnut oil (6g per 94g diet), to give 8 percent oil content, for 42 days. Diabetic rats had elevated levels of glucose (322.61 ± 9.49), glycosylated hemoglobin (HbA1c), vitamin E, thiobarbituric acid reactive substances (TBARS), and lipid hydroperoxides (HP) and decreased levels of hemoglobin (Hb), vitamin C, and reduced glutathione (GSH). An increase in the activities of glucose-6-phosphatase and fructose-1,6-bisphosphatase and a decrease in hexokinase activity also were observed in the liver and kidney. When diabetic rats were fed groundnut oil, a significant reduction in glucose (244.04 ± 11.66), HbA1c, TBARS, HP levels, and glucose-6-phosphatase and fructose-1,6-bisphosphatase activities and an elevation in Hb, vitamin E, GSH levels, and hexokinase activity were observed. Diabetic rats had elevated total cholesterol (TC), VLDL-cholesterol, LDL-cholesterol, and triglycerides (TG) and decreased HDL-cholesterol. Diabetic rats fed groundnut oil showed a small but significant reduction in TC, VLDL-C, LDL-C, and TG and an elevation in HDL-C. Groundnut oil consumption slightly but significantly decreases the blood glucose, HbA1c, lipid peroxidation, and lipid profile and increases antioxidant levels in diabetic rats.

Currently, there are 150 million diabetics worldwide, and this number is likely to increase to 300 million or more by the year 2025 due to increases in sedentary lifestyles, consumption of energy-rich diets and obesity [1,2]. While the management of diabetes mellitus includes diet, exercise, oral hypoglycemic agents, and insulin, these do not effectively prevent the complications of diabetes mellitus [3]. In modern medicine, there is still no satisfactory effective therapy available to cure diabetes [4]. Therefore, it has become necessary to search for an economically and therapeutically effective treatment, especially for usage in developing and under-developed countries. Many indigenous medicinal plants have been found to be useful to successfully manage diabetes [5].

Groundnut oil is widely used in south India for cooking. Groundnut oil contains 46 and 32 percent of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), respectively [6]. Rasmussen et al. noted a reduction in peak plasma glucose concentration with the consumption of a monounsaturated fatty acid-rich diet [7]. Reports are available on the effect of groundnut oil on normal and high-fat diets [8] and myocardial infarction [9]. No investigation has been carried out to study the effect of groundnut oil on glycemic control in diabetic rats. Since groundnut oil contains 46 percent of MUFA, we were interested in exploring the role of groundnut oil in diabetes.

In diabetes, hyperglycemia results in the generation of free radicals [10] due to autoxidation of glucose [11] and glycosylation of proteins [12]. Free radicals react with lipids and cause peroxidative changes that result in enhanced lipid peroxidation [13]. The level of lipid peroxidation in cells is controlled by various cellular defense mechanisms consisting of enzymatic and nonenzymatic scavenging systems [14]. The efficiency of the antioxidant defense mechanism is altered in diabetes [15]. Hence, in this study, we investigate the effect of groundnut oil on blood glucose, carbohydrate metabolic enzymes, lipid profile, lipid peroxidation, and nonenzymatic antioxidants in normal and STZ-diabetic rats.

Materials and Methods

Oil and treatment diet

Standard pellet diet and oil-free diet were purchased from Pranav Agro Industries Ltd., Pune, India. Groundnut oil (SVS groundnut oil, trade name) was purchased from the local market. The oil was stored in a jar at 4 °C. The standard pellet diet contained 8 percent oil. Since the oil-free diet contained 2 percent oil, 94 g of this diet was mixed with 6 g of groundnut oil to make an 8 percent oil content.

Chemicals

Streptozotocin was procured from Sigma-Aldrich, St. Louis, United States, and glibenclamide from Hoechts, Frankfurt, Germany. All other chemicals used were of analytical grade and obtained from E. Merck, Darmstadt, Germany, and Hi-media, India.

Experimental animals

Adult albino female Wistar rats with body weight of 180 to 200 g bred in Central Animal House, Department of Experimental Medicine, Rajah Muthiah Medical College, Annamalai University, were used in this study. The feed and water were provided ad libitum to the animals.

Experimental induction of diabetes

The animals were made diabetic with an intraperitoneal injection of STZ at a dose of 40 mg/kg b-wt dissolved in citrate buffer (0.1 M, pH 4.5). STZ-injected animals exhibited massive glycosuria and hyperglycemia within a few days. Diabetes was confirmed in the overnight-fasted rats by measuring blood glucose concentration 96 hr after injection with STZ. The rats with blood glucose above 240 mg/dl were considered to be diabetic and used for the experiment.

Experimental design

The animals were randomly divided into five groups of six animals each:

  • Group I: Normal

  • Group II: Normal + groundnut oil diet

  • Group III: Diabetic control

  • Group IV: Diabetic + groundnut oil diet

  • Group V: Diabetic + glibenclamide (600 µg/kg b-wt)

After 42 days of treatment, the 12 hr- fasted animals were sacrificed by cervical decapitation between 8 a.m. and 9 a.m. Blood was collected in tubes containing a mixture of potassium oxalate and sodium fluoride (1:3) for the estimation of blood glucose and in tubes with ethylenediaminetetra acetic acid (EDTA) for the estimation of HP, TBARS, GSH, vitamins C and E, and lipid profile. Tissues such as liver and kidney were collected and stored at 4 °C for the estimations of enzymes.

Biochemical estimations

Blood glucose was estimated by the method of Sasaki et al. [16]. Hb and HbA1c were estimated by the methods of Drabkin and Austin [17] and Sudhakar and Pattabiraman [18], respectively. The activities of glucokinase, glucose-6-phosphatase and fructose-1, 6-bisphosphatase were assayed by the methods of Brandstrup et al. [19], Koide and Oda [20], and Gancedo and Gancedo [21], respectively. Plasma vitamin C, vitamin E, GSH, TBARS, and HP were estimated by the methods of Roe and Kuether [22], Baker et al. [23], Ellman [24], Nichans and Samuelson [25] and Jiang et al. [26], respectively. TC [27], HDL-C [28], and TG [29] were measured. LDL-C was calculated by Friedwald's formula [30].

Statistics

Results were expressed as means ± SD, for six rats in each group. Data were analyzed using one-way analysis of variance (ANOVA), and group means were compared with Duncan's Multiple Range Test (DMRT) [31] using SPSS-10.

Results

Table 1 shows the effect of groundnut oil on body weight and blood glucose in normal and STZ-diabetic rats. A significant weight loss was observed in the diabetic control group. The weight loss was minimal in the oil-treated group, but significant improvement of weight was observed in the group treated with standard drugs. A drastic increase in blood glucose level was found in the diabetic control group. A small but significant reduction in blood glucose level was found in the diabetic animals fed groundnut oil. The reduction was highly significant in the drug-treated group.

Table 2 illustrates the effect of substitution of oil on Hb and HbA1c levels in normal and STZ-diabetic rats. Hb level decreased significantly, while an increase in HbA1c was observed in diabetic rats when compared with normal rats. Significant improvement in Hb levels and a decrease in HbA1c were observed in diabetic animals treated with groundnut oil and glibenclamide, though it was more prominent in the drug-treated group.

Table 3 shows the effect of groundnut oil on carbohydrate metabolic enzymes in tissues of normal and STZ-diabetic rats. The hexokinase activity decreased, whereas the activities of gluconeogenic enzymes such as glucose-6-phosphatase and fructose-1, 6-bisphosphatase increased in the liver and kidney of diabetic rats when compared with normal rats. A significant increase of hexokinase and reduction in glucose-6-phosphatase and fructose-1, 6-bisphosphatase activities were observed in the groups treated with groundnut oil and glibenclamide when compared with diabetic controls.

Table 4 illustrates the effect of groundnut oil on TBARS and HP in the plasma of normal and STZ-diabetic rats. A significant increase in TBARS and HP was observed in diabetic rats when compared with normal rats. TBARS and HP decreased significantly in the plasma of diabetic rats fed with groundnut oil and treated with glibenclamide when compared with diabetic control rats. The decrease in the levels of TBARS and HP was more remarkable in glibenclamide-treated rats.

Table 5 shows the effect of groundnut oil on antioxidants in the plasma of normal and STZ-diabetic rats. A significant reduction of plasma vitamin C and GSH and increase of vitamin E were observed in diabetic rats when compared with control rats. Significant increase in vitamin E and GSH were found in diabetic rats fed with groundnut oil when compared with diabetic rats. The levels of vitamin C and GSH significantly increased while vitamin E decreased in glibenclamide-treated rats when compared with diabetic controls. An increase in vitamin E also was observed in normal rats fed with oil when compared with the control group.

Table 6 shows the effect of groundnut oil in the diet on plasma TC, VLDL-C, LDL-C, HDL-C, TG, and TC/HDL-C ratio in STZ-diabetic rats. In our study, diabetic rats had elevated levels of TC, VLDL-C, LDL-C, and TG and decreased levels of HDL-C when compared with normal rats. Diabetic rats fed with groundnut oil showed a small but significant reduction in the levels of TC, VLDL-C, LDL-C, and TG and elevation in HDL-C level when compared with diabetic controls, but diabetic animals treated with glibenclamide showed better improvement.

Discussion

STZ is a commonly employed compound for the induction of diabetes mellitus in experimental rats [32]. It causes DNA strand breaks in pancreatic islets, stimulates nuclear poly (ADP-ribose) synthetase, and thus depletes the intracellular NAD⁺ and NADP⁺ levels, which inhibits proinsulin synthesis and induces diabetes [33]. The decrease in body weight in diabetic rats shows that the loss or degradation of structural proteins is due to diabetes, and the structural proteins are known to contribute to the body weight [34]. In diabetic rats fed with groundnut oil, the weight loss was minimized, which may be due to the reduction of blood glucose. Groundnut oil-fed diabetic rats showed a significant reduction in blood glucose level. The reduction may be due to the presence of MUFA. Rasmussen et al. have reported reduction in peak plasma glucose concentration with the consumption of a MUFA-rich diet [7]. An earlier report from our laboratory shows that dietary substitution of sesame oil showed a better reduction of blood glucose 322.61 ± 9.49 to 222.02 ± 8.27) than groundnut oil in STZ-diabetic rats [35].

Insulin generally has an anabolic effect on protein metabolism in that it stimulates protein synthesis and retards protein degradation [36]. Previous reports have shown that protein synthesis is decreased in all tissues due to decreased production of ATP and absolute or relative deficiency of insulin [37], which may be responsible for the decreased level of Hb in diabetic rats. HbA1c comprises 3.4 percent to 5.8 percent of total Hb in normal human red cells, but it is increased in patients with overt diabetes mellitus [38]. It was found to increase in diabetic patients up to 16 percent [39], and the level of HbA1c is monitored as a reliable index of glycemic control in diabetes [40]. Elevated levels of HbA1c and reduced levels of Hb observed in our study reveal that diabetic animals had prior high blood glucose level. Groundnut oil-fed diabetic rats showed an increase in Hb level and decrease in HbA1c level, which may be due to the reduction of the blood glucose level.

In experimental diabetes, enzymes of glucose metabolism are markedly altered. Persistent hyperglycemia is a major contributor to such metabolic alterations that lead to the pathogenesis of diabetic complications, especially microvascular diseases [41]. One of the key enzymes in the catabolism of glucose is glucokinase, which phosphorylates glucose to glucose-6-phosphate [42]. In our study, the glucokinase activity was decreased in the liver of diabetic rats, which may be due to the deficiency of insulin. Groundnut oil-fed diabetic rats showed an elevated activity of glucokinase, which may be associated with reduced blood glucose.

Insulin decreases gluconeogenesis by decreasing the activities of key enzymes, such as glucose-6-phosphatase, fructose-1, 6-bisphosphatase, phosphoenolpyruvate carboxykinase, and pyruvate carboxykinase [43]. Glucose-6-phosphatase is an important enzyme in homeostasis of blood glucose as it catalyzes the terminal step both in gluconeogenesis and glycogenolysis [44]. Fructose-1, 6-bisphosphase is one of the key enzymes of gluconeogenic pathway. It is present in liver and kidney but absent from heart, muscle, and smooth muscle. In our study, the increased activities of glucose-6-phosphatase and fructose-1, 6-bisphosphatase in liver and kidney of diabetic rats may be due to insulin deficiency. In oil-fed diabetic rats, the activities of these two enzymes were significantly reduced, which is responsible for the improved glycemic control.

Diabetes mellitus has been reported to generate reactive oxygen species (ROS). ROS, such as free hydroxyl radicals (֗OH) and superoxide (O2֗ˉ ), can cause lipid peroxidation [45]. Membrane lipid peroxidation results in loss of PUFA, decreased membrane fluidity, and loss of enzyme and receptor activity. The products of lipid peroxidation are capable of interacting with DNA and cause oxidative damage [46]. In our study, the lipid peroxidation markers such as TBARS and HP were significantly increased in the plasma of STZ-diabetic rats as reported earlier [47]. The levels of TBARS and HP were significantly decreased in diabetic rats fed with oil, which may be associated with decreased blood glucose and the presence of vitamin E in the oil.

Oxidative stress occurs when there is an imbalance between free radical reaction and the scavenging capacity of the antioxidative defense mechanism of the organism [48]. The nonenzymatic antioxidants such as GSH, vitamin C, and vitamin E are interrelated by recycling process [49]. Glutathione is the most important non-protein compound-containing thiol group, which acts as a substrate for glutathione transferase and glutathione peroxidase involved in preventing the deleterious effect of oxygen radicals [50]. In our study, diabetic rats showed a significant decrease in the level of GSH, which may be due to increased utilization. In oil-fed diabetic rats, a significant improvement in GSH was observed. This could be due to the decreased utilization of GSH.

Vitamin C is one of the most powerful natural antioxidants [51]. It is capable of regenerating α-tocopherol from the tocopheroxyl radical that is formed upon the inhibition of lipid peroxidation by vitamin E [52]. Vitamin C has been reported to contribute up to 24 percent of the total peroxyl radical-trapping antioxidant activity (TRAP) [53]. In our study, vitamin C was decreased significantly in the plasma of diabetic rats as reported earlier [54]. Groundnut oil-fed diabetic rats did not show any variation in vitamin C levels. Among lipid soluble antioxidants, α-tocopherol plays a central role as it controls radical-induced lipoprotein lipid peroxidation [55]. In our study, vitamin E level was also significantly elevated in the plasma of diabetic rats as reported earlier [56]. The increased level of α-tocopherol could be due to the increased release from membrane damage by ROS. Groundnut oil-fed diabetic rats showed a significant elevation of vitamin E in the plasma of diabetic rats. The increased level might be due to the presence of vitamin E in the oil.

The levels of serum lipids are usually elevated in diabetes mellitus and such an elevation represents a risk factor for coronary heart disease [57]. Diabetic rats fed with groundnut oil showed a small but significant reduction in levels of TC, VLDL-C, LDL-C, and TG and elevation in HDL-C levels when compared with diabetic controls. This could be due to the presence of MUFA and PUFA in the oil. There have been numerous studies in humans and animals that have demonstrated that oils containing saturated fatty acids raise serum TC, TG, and, in particular, LDL-C levels, while those enriched in unsaturated fatty acids lower TC, TG, and LDL-C [58,59]. Diets high in monounsaturated fatty acids have been found to be relatively hypocholesterolemic or hypotriacylglycerolemic, respectively [60,61].

In conclusion, our results show that groundnut oil substitution in the diet influences blood glucose, lipid profile, lipid peroxidation, and antioxidants beneficially in STZ-diabetic rats.

Table 1. Effect of groundnut oil in diet on blood glucose and body weight in normal and diabetic animals.

Body weight (g) Blood glucose (mg/dL)
Group Before treatment (0 day) After treatment (42 days) Before treatment (0 day) After treatment (42 days)
Normal 185.16 ± 3.31 208.66 ± 4.22a 80.95 ± 5.82 88.09 ± 4.32b
Normal + groundnut oil diet 176.50 ± 2.25 198.16 ± 3.18a,b 75.54 ± 4.23 72.61 ± 3.68a
Diabetic control 178.50 ± 3.01 128.16 ± 3.12c 251.78 ± 9.78 322.61 ± 9.49e
Diabetic + groundnut oil diet 173.50 ± 3.14 159.66 ± 3.55b 259.51 ± 11.44 244.04 ± 11.66d
Diabetic + glibenclamide (600 µg/kg b-wt) 181.50 ± 4.37 201.50 ± 5.39a,b 258.33 ± 7.37 122.11 ± 3.61c
Open in a new tab

Values are means ± SD for six rats in each group. Values sharing a common superscript in a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]).

Table 2. Effect of groundnut oil in diet on Hb and HbA1c in normal and diabetic animals.

Group Hb (g/dL) HbA1c (mg/g of Hb)
Normal 10.92 ± 0.37a 0.39 ± 0.01b
Normal + groundnut oil diet 10.85 ± 0.49a 0.34 ± 0.02a
Diabetic control 6.12 ± 0.15d 1.10 ± 0.03e
Diabetic + groundnut oil diet 6.79 ± 0.49c 0.99 ± 0.02d
Diabetic + glibenclamide (600 µg/kg b-wt) 9.73 ± 0.49b 0.49 ± 0.03c
Open in a new tab

Values are means + SD for six rats in each group. Values sharing a common superscript in a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]).

Table 3. Effect of groundnut oil in diet on the activities of carbohydrate metabolic enzymes in liver and kidney of normal and diabetic animals.

Glucokinase (Hexokinase D) (Unit*/h/mg protein Glucose-6-phosphatase (Unit**/min/mg/protein) Fructose-1,6-phosphatase (Unit***/h/mg/protein)
Group Liver Liver Kidney Liver Kidney
Normal 0.260 ± 0.023a 0.165 ± 0.011a 0.187 ± 0.036a 0.412 ± 0.027a 0.814 ± 0.063a
Normal + groundnut oil diet 0.270 ± 0.012a 0.156 ± 0.022a 0.176 ± 0.024a 0.395 ± 0.028a 0.757 ± 0.061a
Diabetic control 0.079 ± 0.009d 0.457 ± 0.014d 0.272 ± 0.016d 0.714 ± 0.029d 1.169 ± 0.042c
Diabetic + groundnut oil diet 0.116 ± 0.009c 0.397 ± 0.014c 0.236 ± 0.016c 0.656 ± 0.037c 1.016 ± 0.151b
Diabetic + glibenclamide (600 µg/kg b-wt) 0.216 ± 0.014b 0.244 ± 0.014b 0.203 ± 0.018b 0.481 ± 0.035b 0.802 ± 0.037a
Open in a new tab

Values are means ± SD for six rats in each group. Values sharing a common superscript in a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]). *µmoles of glucose phosphorylated; **µmoles of inorganic phosphorous liberated; ***µmoles of inorganic phosphorous liberated.

Table 4. Effect of groundnut oil in diet on TBARS and HP in plasma of normal and diabetic animals.

Group TBARS (mmol/dl) HP (x 10-5 mmol/dl)
Normal 0.175 ± 0.038a 9.81 ± 0.98b
Normal + groundnut oil diet 0.162 ± 0.030a 8.32 ± 0.91a
Diabetic control 0.350 ± 0.038c 24.15 ± 1.07e
Diabetic + groundnut oil diet 0.262 ± 0.041b 22.48 ± 0.74d
Diabetic + glibenclamide (600 µg/kg b-wt) 0.187 ± 0.041a 11.06 ± 0.59c
Open in a new tab

Values are means ± SD for six rats in each group. Values sharing a common superscript in a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]).

Table 5. Effect of groundnut oil in diet on vitamin C, vitamin E, and GSH in plasma of normal and diabetic animals.

Group Vitamin C (mg/dl) Vitamin E (mg/dl) GSH (mg/dl)
Normal 1.83 ± 0.08a 6.32 ± 0.24a 31.47 ± 2.00b
Normal + groundnut oil diet 1.36 ± 0.08b 7.42 ± 0.24b 34.26 ± 2.21a
Diabetic control 0.93 ± 0.08c 14.66 ± 0.22d 18.62 ± 2.37d
Diabetic + groundnut oil diet 0.66 ± 0.08d 18.92 ± 0.27e 23.83 ± 1.99c
Diabetic + glibenclamide (600 µg/kg b-wt) 1.40 ± 0.08b 9.57 ± 0.27c 28.81 ± 3.10b
Open in a new tab

Values are means ± SD for six rats in each group. Values sharing a common superscript in a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]).

Table 6. Effect of groundnut oil in diet on TC, VLDL-C, LDL-C, HDL-C, and TG in normal and diabetic animals.

Group TC (mg/dl) VLDL-C (mg/dl) LDL-C (mg/dl) HDL-C (mg/dl) TG (mg/dl)
Normal 82.00 ± 1.74a 16.29 ± 1.15a 24.71 ± 2.13a 41.10 ± 3.27d 81.45 ± 2.00a
Normal + groundnut oil diet 84.20 ± 2.20a 17.91 ± 1.32b 31.44 ± 3.14b 35.15 ± 2.55c 90.38 ± 2.41b
Diabetic control 131.20 ± 1.09d 36.09 ± 2.63d 67.13 ± 5.24d 27.78 ± 1.89a 180.45 ± 4.85d
Diabetic + groundnut oil diet 116.33 ± 1.50c 32.00 ± 3.12c 54.68 ± 4.33c 30.88 ±; 2.17b 160.95 ± 3.74c
Diabetic + glibenclamide (600 µg/kg b-wt) 91.66 ± 1.75b 18.63 ± 1.07b 33.59 ± 2.98b 40.02 ± 3.95d 93.15 ± 2.29b
Open in a new tab

Values are means ± SD for six rats in each group. Values sharing a common superscript in a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]).

Abbreviations

ANOVA

analysis of variance

DMRT

Duncan's Multiple Range Test

LDL

low-density lipoprotein

GSH

glutathione

Hb

hemoglobin

HbA1c

glycosylated hemoglobin

HP

hydroperoxides

MUFA

monounsaturated fatty acids

PUFA

polyunsaturated fatty acids

STZ

streptozotocin

TBARS

thiobarbituric acid reactive substances

TC

total cholesterol

V-LDL

very-low-density lipoprotein

References

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimations and projections. Diabetes Care. 1998;21:1414–1431. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
  2. Yajnik CS. The insulin resistance epidemic in India: fetal origin, later lifestyle, or both. Nutr Rev. 2001;59:1–9. doi: 10.1111/j.1753-4887.2001.tb01898.x. [DOI] [PubMed] [Google Scholar]
  3. Plumbo PJ. Glycemic control, mealtime glucose excursions and diabetic complications in type 2 diabetes mellitus. Mayo Clin Proc. 2001;76:609–618. [PubMed] [Google Scholar]
  4. Piedrola G, Novo E, Escober F, Garcia-Robles R. White blood cell count and insulin resistance in patients with coronary artery disease. Ann Endocrinol. 2001;62:7–10. [PubMed] [Google Scholar]
  5. Joy KL, Kuttan R. Antidiabetic activity of Picorrhiza kurroa extract. J Ethnopharmacol. 1999;167:143–148. doi: 10.1016/s0378-8741(98)00243-8. [DOI] [PubMed] [Google Scholar]
  6. The USDA Nutrient Database for Standard Reference. August. Washington: USDA; 1997. [Google Scholar]
  7. Rasmussen OW, Thomsen C, Hansen KW, Vesterlund M, Winter E, Hermansen K. Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects. Diabetes Care. 1993;16:1565–1571. doi: 10.2337/diacare.16.12.1565. [DOI] [PubMed] [Google Scholar]
  8. Srinivasan KN, Pugalendi KV. Effect of excessive intake of thermally oxidized sesame oil on lipids, lipid peroxidation and antioxidants’ status in rats. Ind J Exp Biol. 2000;38:777–780. [PubMed] [Google Scholar]
  9. Nageswari K, Banerjee R, Menon VP. Effect of saturated, w-3 and w-6 polyunsaturated fatty acids on myocardial infarction. J Nutr Biochem. 1999;10:338–343. doi: 10.1016/s0955-2863(99)00007-8. [DOI] [PubMed] [Google Scholar]
  10. Giardino I, Edelstein D, Brownlee M. BCL-Z expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation end products in bovine endothelial cells. J Clin Invest. 1996;46:223–234. doi: 10.1172/JCI118563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hunt JV, Wolff SP. Oxidative glycation and free radical production: a casual mechanism of diabetic complication. Free Radic Res. 1991;12-13:115–123. doi: 10.3109/10715769109145775. [DOI] [PubMed] [Google Scholar]
  12. Gillery P, Monboisse JC, Maquat FX, et al. Glycation of protein as a source of superoxide. Diabetes Metab. 1988;14:25–30. [PubMed] [Google Scholar]
  13. Girotti MW. Mechanisms of lipid peroxidation. Free Radic Biol Med. 1985;1:87–95. doi: 10.1016/0748-5514(85)90011-x. [DOI] [PubMed] [Google Scholar]
  14. Halliwell B, Gutteridge JMC. Lipid peroxidation oxygen radicals, cell damage, and antioxidant therapy. Lancet. 1994;1:1396–1397. doi: 10.1016/s0140-6736(84)91886-5. [DOI] [PubMed] [Google Scholar]
  15. Wohaieb SA, Godin DV. Alleviations in free radical tissue defense mechanisms in streptozotocin-induced diabetes in rats: Effects of insulin treatment. Diabetes. 1987;36:1014–1018. doi: 10.2337/diab.36.9.1014. [DOI] [PubMed] [Google Scholar]
  16. Sasaki TM, Sonnae A. Effect of acetic acid concentration on the color reaction in the o-toluidine-boric acid method for blood glucose estimation. Rinsho Kagaku. 1972;1:346–353. [Google Scholar]
  17. Drabkin DL, Austin JM. Spectro­photometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem. 1932;98:719–733. [Google Scholar]
  18. Sudhakar NS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chim Acta. 1981;109:267–274. doi: 10.1016/0009-8981(81)90312-0. [DOI] [PubMed] [Google Scholar]
  19. Brandstrup N, Kirk JE, Brunic C. Determination of hexokinase in tissues. J Gerontol. 1957;12:166–171. doi: 10.1093/geronj/12.2.166. [DOI] [PubMed] [Google Scholar]
  20. Koide H, Oda T. Pathological occurrence of glucose phosphatase in serum in liver diseases. Clin Chim Acta. 1959;4:554. doi: 10.1016/0009-8981(59)90165-2. [DOI] [PubMed] [Google Scholar]
  21. Gancedo JM, Gancedo C. Fructose-1, 6-bisphophatase, phophofructokinase and glucose-6-phosphate dehydrogenase from fermenting yeast. Arch Microbiol. 1971;76:132–138. doi: 10.1007/BF00411787. [DOI] [PubMed] [Google Scholar]
  22. Roe JH, Kuether CA. Detection of ascorbic acid in whole blood and urine through the 2, 4-DNPH derivative of dehydroascorbic acid. J Biol Chem. 1943;147:399–407. [Google Scholar]
  23. Baker H, Frankel O, De Angelis B, Feingold S. Plasma α-tocopherol in man at various time intervals after ingesting free or acetylated tocopherol. Nutr Rep Int. 1980;21:531–536. [Google Scholar]
  24. Ellman GC. Tissue sulfhydryl groups. Biochem Biophys. 1959;82:70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  25. Nichans WG, Samuelson B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968;6:126–130. doi: 10.1111/j.1432-1033.1968.tb00428.x. [DOI] [PubMed] [Google Scholar]
  26. Jiang ZY, Hunt JV, Wolff SP. Detection of lipid hydroperoxides using the “Fox” method. Anal Biochem. 1992;202:384–389. doi: 10.1016/0003-2697(92)90122-n. [DOI] [PubMed] [Google Scholar]
  27. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;20:1075. [PubMed] [Google Scholar]
  28. Warnick GR, Nguyen T, Alberts AA. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 1985;31:217. [PubMed] [Google Scholar]
  29. Rifai N, Bachorik PS, Alberts JJ. Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia: W.B. Saunders Company; 1999. pp. 809–861. [Google Scholar]
  30. Friedwald WT, Levy RJ, Fredricken DS. Estimation of HDL-c in the plasma without the use of preparative ultracentrifuge. Clin Chem. 1972;18:449. [PubMed] [Google Scholar]
  31. Bennet P, Franklin NH. Statistical Analysis in Chemistry and Chemical Industry. New York: John Wiley and Sons; 1967. pp. 208–227. [Google Scholar]
  32. Tomlinson KC, Gardiner SM, Hebden R, Bennet T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev. 1992;44:103–150. [PubMed] [Google Scholar]
  33. Wilson GL, Hartig PC, Patton NJ, LeDoux SP. Mechanisms of nitrosourea induced β-cell damage. Activation of poly (ADP-ribose) synthetase and cellular distribution. Diabetes. 1988;37:213–216. doi: 10.2337/diab.37.2.213. [DOI] [PubMed] [Google Scholar]
  34. Rajkumar L, Govidarajulu P. Increased degradation of dermal collagen in diabetic rats. Ind J Exp Biol. 1991;29:1081–1083. [PubMed] [Google Scholar]
  35. Ramesh B, Saravanan R, Pugalendi KV. Influence of sesame oil on blood glucose, lipid peroxidation and antioxidants’ status in streptozotocin diabetic rats. J Med Food. 2005;8:378–381. doi: 10.1089/jmf.2005.8.377. [DOI] [PubMed] [Google Scholar]
  36. Murray RR, Granner DK, Mayes PA, Rodwell VW. Harper's Biochemistry. 25th ed. Stamford, Connecticut: Appleton and Lange; 1999. pp. 610–617. [Google Scholar]
  37. Chatterjea MN, Rana Shinde. Textbook of Medical Biochemistry. New Delhi, India: Jaypee Brothers Medical Publishers Pvt Ltd; 1994. Metabolism of carbohydrate; p. 421. [Google Scholar]
  38. Paulsen EP. A1c in childhood of diabetes. Metabolism. 1973;22:269–271. doi: 10.1016/0026-0495(73)90170-4. [DOI] [PubMed] [Google Scholar]
  39. Koeing RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med. 1976;295:417–420. doi: 10.1056/NEJM197608192950804. [DOI] [PubMed] [Google Scholar]
  40. Gabbay KH. Glycosylated hemoglobin and diabetic control. N Engl J Med. 1976;295:443–444. doi: 10.1056/NEJM197608192950810. [DOI] [PubMed] [Google Scholar]
  41. West KM. Hyperglycemia as a cause of long-term complications. In: Keen H, Jarret J, editors. Complication of Diabetes. 2nd ed. London: Edward Arnold; 1981. pp. 3–18. [Google Scholar]
  42. Laakso M, Malkki M, Deeb SS. Amino acid substituents in hexokinase II among patients with NIDDM. Diabetes. 1995;44:330–334. doi: 10.2337/diab.44.3.330. [DOI] [PubMed] [Google Scholar]
  43. Murray RR, Granner DK, Mayes PA, Rodwell VW. Harper's Biochemistry. 25th ed. Stamford, Connecticut: Appleton and Lange; 2000. pp. 610–617. [Google Scholar]
  44. Hers HG, Van Hoff F, Barsy T. Glycogen storage diseases. In: Scriver CR, Braudet AL, Charles R, Sly WS, Valle D, editors. The Metabolic Basis of Inherited Diseases. New York: McGraw-Hill; 1989. p. 425. [Google Scholar]
  45. Matkovics S, Kotorman M, Varga IS, et al. Proantioxidant and filtration changes in blood of type 1 diabetic patient. Acta Physiol Hung. 1997;85:99–106. [PubMed] [Google Scholar]
  46. Maillard B, Ingold KU, Sciaro JC. Rate constants for the reaction of free radicals with oxygen in solution. J Am Chem Soc. 1983;105:5095–5099. [Google Scholar]
  47. Zhang XF, Tan BK. Antihypergly­caemic and antioxidant properties of Andrographis particulate in normal and diabetic rats. Clin Exp Pharmacol Physiol. 2000;27:358–363. doi: 10.1046/j.1440-1681.2000.03253.x. [DOI] [PubMed] [Google Scholar]
  48. Sies H. Oxidative Stress: from Basic Research to Clinical Applications. London: Academic Press; 1991. p. 936. [DOI] [PubMed] [Google Scholar]
  49. Packer L, Tritschler HJ, Wessel K. Neuroprotection by metabolic antioxidant α-lipoic acid. Free Radic Biol Med. 1997;22:359–378. doi: 10.1016/s0891-5849(96)00269-9. [DOI] [PubMed] [Google Scholar]
  50. Levine WG. Interaction of ascorbic acid and α-tocopherol. Ann Nutr Acad Sci. 1990;498:186–199. [Google Scholar]
  51. Bendich A, Machlin LJ, Scandura O, Burton GW, Wayner ODM. The antioxidant role of vitamin C. Free Radic Biol Med. 1986;2:419–444. [Google Scholar]
  52. Niki E, Tsuchiya J, Tanimura R, Kamiya Y. Regeneration of vitamin E from α-tocopheroxyl radical by glutathione and vitamin C. Chem Lett. 1982;41:789–792. [Google Scholar]
  53. Atanasiu RL, Stea D, Mateescu MA. Direct evidence of ceruloplasmin antioxidant properties. Mol Cell Biochem. 1998;189:127–135. doi: 10.1023/a:1006945713860. [DOI] [PubMed] [Google Scholar]
  54. Garg M, Bansal DD. Protective antioxidant effect of vitamin C and vitamin E in STZ-induced diabetic rats. Ind J Exp Biol. 2000;28:101–104. [PubMed] [Google Scholar]
  55. Biegelsen ES, Vita JA. Human studies of antioxidants and vascular function. In: Keaney JF Jr., editor. Oxidative Stress and Vascular Disease. Netherlands: Dordrecht Acedemic Publishers; 1999. pp. 213–243. [Google Scholar]
  56. Stanley Mainzen Prince P, Menon VP. Antioxidant activity of Tinospora cordifolia roots in experimental diabetes. J Ethnopharmacol. 1999;65:277–281. doi: 10.1016/s0378-8741(98)00164-0. [DOI] [PubMed] [Google Scholar]
  57. Davidson MB. Diabetes Mellitus: Diagnosis and Treatment. Hoboken, New Jersey: Wiley; 1981. p. 109. [Google Scholar]
  58. The Expert Panel. Report of the National Cholesterol Education Program Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med. 1988;148:36–64. [PubMed] [Google Scholar]
  59. Mensink RP, Katan MB. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low density and high density lipoprotein cholesterol in healthy women and men. N Eng J Med. 1989;321:436–441. doi: 10.1056/NEJM198908173210705. [DOI] [PubMed] [Google Scholar]
  60. Matson FH, Grundy SM. Comparison effect of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985;25:194–202. [PubMed] [Google Scholar]
  61. Bairati I, Roy L, Mayer F. Effect of fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease. Can J Cardiol. 1992;8:41–46. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES